Start Leitlinien >  » Hypertonie >  Referenzen 
Hypertonie Referenzen
Diese Seite zum Ausdrucken als .pdf-Datei abrufen

Hypertonie

Evidenzbasierte Leitlinie zu Diagnose und Therapie
Entwickelt durch das medizinische Wissensnetzwerk evidence.de
der Universität Witten/Herdecke

Referenzen

Hinweise: Nach Möglichkeit wurden Links zu den zitierten Dokumenten respektive den Zusammenfassungen gelegt. Die Links werden erst bei einem Update der Leitlinie erneut überprüft. Sollten Sie Probleme mit „toten Links“ haben, teilen Sie uns dies bitte unter info@evidence.de mit. Oftmals reicht die im Link enthaltene Nummer (PMID), um bei Pubmed/Medline (
http://www4.ncbi.nlm.nih.gov/PubMed ) den gewünschten Artikel wieder aufzufinden.
Mit Ausnahme von nationalen oder internationalen Leitlinien wurden die Referenzen einer
Evidenzklasse zugeordnet.


1. Leitlinien-Info-Modul „Hypertonie“ der Ärztlichen Zentralstelle für Qualitätssicherung (ÄZQ), 2002.
http://www.aezq.de/leitliniecv.htm#infomodul


2. Leitlinien-Clearing-Bericht „Hypertonie“ der Ärztlichen Zentralstelle für Qualitätssicherung (ÄZQ), 2000.
http://www.leitlinien.de/infohypertonie.htm  


3. „Hypertension in older people“ des Scottish Intercollegiate Guidelines Network (SIGN), 2001.
http://www.show.scot.nhs.uk/sign/guidelines/fulltext/49


4. „Health Care Guideline: Hypertension diagnosis and treatment“ des Institute for Clinical Systems Improvement (ISCI), 2002.
http://www.icsi.org/guide/HTN.pdf


5. „Guidelines for management of hypertension: report of the third working party of the British Hypertension Society“ der British Hypertension Society (BHS), 1999.
http://www.hyp.ac.uk/bhs/managemt.html


6. „Leitlinien für die Prävention, Erkennung, Diagnostik und Therapie der arteriellen Hypertonie“ der Deutschen Hochdruckliga und der Deutschen Hypertonie Gesellschaft, 2001.
http://www.uni-duesseldorf.de/AWMF/ll/ihypto01.htm


7. „1999 Canadian recommendations for the management of hypertension“ der Canadian Medical Association (CMA), 1999.
http://www.cma.ca/cmaj/vol-161/issue-12/hypertension/hyper-e.pdf


8. „Lifestyle modifications to prevent and control hypertension“ der Canadian Medical Association (CMA), 1999.
http://www.cma.ca/cmaj/vol-160/issue-9/hypertension/hyper.pdf


9. The Sixth Report Of The Joint National Committee On Prevention; Detection, Evaluation, and Treatment Of High Blood Pressure (JNC VI). National Institutes of Health, Lung and Blood Institute, National High Blood Pressure Education Program, NIH Publication No. 98-4080, November 1997.
http://www.nhlbi.nih.gov/guidelines/hypertension/jncintro.htm


10. „Empfehlungen zur Therapie der arteriellen Hypertonie“ der Arzneimittelkommission der deutschen Ärzteschaft (AKDÄ), 1998.
http://www.akdae.de/Homepage/THERAPIE/Aktuell/Hyperto.pdf


11. US Department of Health and Human Services. Agency for Health Care Policy and Research. Acute Pain Management: operative or medical procedures and trauma. Rockville (MD): The Agency; 1993. Clinical Practice Guideline No.1. AHCPR Publication No.92-0023. p.107.
http://hstat.nlm.nih.gov/hq/Hquest/db/local.arahcpr.arclin.apmc/screen/TocDisplay/s/34949/action/Toc


12. Medizinisches Wissensnetzwerk evidence.de: Leitlinie „Diagnose und Therapie der chronischen Herzinsuffizienz“. Version 5/2001.
http://www.evidence.de/Leitlinien/leitlinien-intern/Herzinsuffizienz_Start/herzinsuffizienz_start.html


13. „Empfehlungen zur Therapie von Fettstoffwechselstörungen“ der Arzneimittelkommission der deutschen Ärzteschaft (AKDÄ). Vol. 2. 1999.
http://www.akdae.de/Homepage/THERAPIE/Aktuell/Fett2.pdf


14. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), National Heart, Lung, and Blood Institue, National Institute of Health, 2001.
http://www.nhlbi.nih.gov/guidelines/cholesterol/index.htm


15. SIGN Guideline. Scottish Intercollegiate guideline network; lipids and the primary prevention of coronary heart disease, 1999.
http://www.show.scot.nhs.uk/sign/guidelines/fulltext


16. Mulrow C, Lau J, Cornell J, Brand M. Pharmacotherapy for hypertension in the elderly (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software.
www.update-software.com/cochrane
Evidenzklasse: Ia


17. Quan A, Kerlikowske K, Gueyffier F, Boissel JP, INDANA investigators. Pharmacotherapy for hypertension in women of different races (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software.
www.update-software.com/cochrane
Evidenzklasse: Ia


18. Ebrahim S, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software.
www.update-software.com/cochrane
Evidenzklasse: Ia


19. Duley L, Henderson-Smart DJ. Drugs for rapid treatment of very high blood pressure during pregnancy (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software.
www.update-software.com/cochrane
Evidenzklasse: Ia


20. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software.
www.update-software.com/cochrane
Evidenzklasse: Ia


21. Mulrow CD, Chiquette E, Angel L, Cornell J, Summerbell C, Anagnostelis B, Brand M, Grimm R Jr. Dieting to reduce body weight for controlling hypertension in adults (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software.
www.update-software.com/cochrane
Evidenzklasse: Ia


22. McAlister, F.A. and S.E. Straus, Evidence based treatment of hypertension: Measurement of blood presssure: an evidence based review. Bmj, 2001. 322(7291): p. 908-11. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11302909&dopt=Ab stract
Volltext:
http://bmj.com/cgi/content/full/322/7291/908?view=full&pmid=11302909
Evidenzklasse: Ia


23. Padwal, R., S.E. Straus, and F.A. McAlister, Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review. Bmj, 2001. 322(7292): p. 977-80. Medline: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11312234&dopt=Ab stract
Volltext:
http://bmj.com/cgi/content/full/322/7292/977?view=full&pmid=11312234
Evidenzklasse: Ia


24. Mulrow, C.D. and M. Pignone, Evidence based management of hypertension: What are the elements of good treatment for hypertension? Bmj, 2001. 322(7294): p. 1107-9. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11337444&dopt=Ab stract
Volltext:
http://bmj.com/cgi/content/full/322/7294/110
Evidenzklasse: Ia


25. Pignone, M. and C.D. Mulrow, Evidence based management of hypertension: Using cardiovascular risk profiles to individualise hypertensive treatment. Bmj, 2001. 322(7295): p. 1164-6. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11348913&dopt=Ab stract
Volltext:
http://bmj.com/cgi/content/full/322/7295/1164
Evidenzklasse: Ia


26. O'Rorke, J.E. and W.S. Richardson, Evidence based management of hypertension: What to do when blood pressure is difficult to control. Bmj, 2001. 322(7296): p. 1229-32. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11358779&dopt=Ab stract
Volltext:
http://bmj.com/cgi/content/full/322/7296/1229
Evidenzklasse: Ia


27. Zentralinstitut für die kassenärztliche Versorgung in der Bundesrepublik Deutschland: Die EvaS-Studie. Köln: Deutscher Ärzte-Verlag, 1989.
Evidenzklasse: III


28. Thamm, M., Blutdruck in Deutschland - Zustandsbeschreibungen und Trends. Gesundheitswesen, 1999. 61(Sonderheft 2): p. S90-S3. [Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10726403&dopt=Ab stract ]
Evidenzklasse: III


29. Statistisches Bundesamt: Gesundheitsbericht für Deutschland. Stuttgart, Metzler-Poeschel, 1998.
http://www.gbe-bund.de
Evidenzklasse: III


30. Rationelle Diagnostik und Therapie in der Inneren Medizin, Urban & Schwarzenberg, Stand 12/2000
http://www.urban.de/medizin/frame_template.htm?/medizin/Leitlinien/85501.htm
Evidenzklasse: IV


31. Schneider CA et al. (2001) Leitlinienadäquate Kenntnisse von Internisten und Allgemeinmedizinern am Beispiel der arteriellen Hypertonie. Z ärztl Fortbild Qualsich 95: 339-344.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11486497&dopt=Ab stract
Evidenzklasse: III


32. Anlauf, M., Antihypertonika, in Arzneiverordnungsreport 2001, U. Schwabe and D. Paffrath, Editors. 2001, Springer: Berlin. p. 193-208.
Evidenzklasse: IV


33. Harder S. et al.: Prescription of cardiovascular drugs in outpatient care: a survey of outpatients in a German university hospital. Int J Clin Pharmacol Ther 1998; 36: 195-201.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9587045&dopt=Abs tract
Evidenzklasse: III


34. Auszug aus „Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme in der 10. Revision (ICD-10)“ [ICD-10-SGB-V, Version 2.0].
www.dimdi.de


35. Hirschl, M.M., Guidelines for the drug treatment of hypertensive crises. Drugs, 1995. 50(6): p. 991-1000. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8612477&dopt=Abs tract
Evidenzklasse: IV


36. Varon, J. and P.E. Marik, The diagnosis and management of hypertensive crises. Chest, 2000. 118(1): p. 214-27. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10893382&dopt=Ab stract
Volltext:
http://www.chestjournal.org/cgi/content/full/118/1/214]
Evidenzklasse: IV


37. Vidt, D.G., Emergency room management of hypertensive urgencies and emergencies. J Clin Hypertens (Greenwich), 2001. 3(3): p. 158-64. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11416701&dopt=Ab stract
Evidenzklasse: IV


38. Wenzel, U.O., et al., Diagnostisches und therapeutisches Vorgehen von Ärzten bei Patienten mit hypertensiver Krise. Eine Umfrage an 56 internistischen Kliniken. Dtsch Med Wochenschr, 1998. 123(15): p. 443-7.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9581158&dopt=Abs tract
Evidenzklasse: IV


39. Beevers, G., G. Y. H. Lip, et al. (2001). ABC of hypertension: Blood pressure measurement. Part I. BMJ 322: 981-985. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11312235&dopt=Ab stract
Volltext:
http://bmj.com/cgi/content/full/322/7292/98
Evidenzklasse: IV


40. Beevers, G., G. Y. H. Lip, et al. (2001). ABC of hypertension: Blood pressure measurement. Part II. BMJ 322: 1043-1047. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11325773&dopt=Ab stract
Volltext:
http://bmj.com/cgi/content/full/322/7293/1043
Evidenzklasse: IV


41. O'Brien, E., G. Beevers, et al. (2001). ABC of hypertension: Blood pressure measurement. Part III. BMJ 322(7294): 1110-1114. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11337446&dopt=Ab stract
Volltext:
http://bmj.com/cgi/content/full/322/7294/1110
Evidenzklasse: IV


42. O'Brien, E., G. Beevers, et al. (2001). ABC of hypertension: Blood pressure measurement. Part IV. BMJ 322(7295): 1167-1170. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11348915&dopt=Ab stract
Volltext:
http://bmj.com/cgi/content/full/322/7295/1167
Evidenzklasse: IV


43. McKay DW et al: Clinical assessment of blood pressure. J Hum Hypertens 1990;4: 639-45.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2096205&dopt=Abs tract
Evidenzklasse: III


44. Perloff D et al. Human blood pressure determination by sphygmomanaometry. Circulation 1993;88: 2460-7.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8222141&dopt=Abs tract
Evidenzklasse: IV


45. Harrison JEG et al. Bilateral indirect and direct arterial pressures. Circulation 1960, 22: 419-36
Evidenzklasse: IIb


46. Mulrow, CD. Evidence-based Hypertension, BMJ books 2001; ISBN 0-7279-1438-3
Evidenzklasse: Ia


47. Waal-Manning, HJ et al. Effects on arm position and support on blood-pressure readings. J Clin Hypertens 1987; 3: 813-814.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3453393&dopt=Abs tract
Evidenzklasse: Ib


48. Cushman WC et al. Effect on back support and stethopscope head on seated blood pressure determinations. Am J Hypertens 1990; 3: 240-241.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2322436&dopt=Abs tract
Evidenzklasse: IV


49. Viol GW et al. Seating as s variable in clinical blood pressure measurement. Am Heart J 1979; 98: 13-14.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=495434&dopt=Abstr act
Evidenzklasse: IV


50. Rudy SF. Take a reading on your blood pressure techniques. Nursing 1986; 16: 46-49.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3636667&dopt=Abs tract
Evidenzklasse: IV


51. Baker EH et al. Confounders on auskultatory blood pressure measurement. J Gen Intern Med 1995; 10: 223-231.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7790985&dopt=Abs tract
Evidenzklasse: IV


52. Russell AE et al. Optimal size of cuff bladder for indirect measurement on arterial pressure in adults. J Hypertens 1989; 7: 607-613.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2681407&dopt=Abs tract
Evidenzklasse: Ib


53. Conceicao S et al. Defects in sphygmomanometers: an important source of error in blood pressure measurement. BMJ 1976; i: 886-888.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1260385&dopt=Abs tract
Evidenzklasse: IV


54. Sprafka JM et al. The effect of cuff size on blood pressure measurement in adults. Epidemiology 1991;2: 214-217.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2054405&dopt=Abs tract
Evidenzklasse: IV


55. Webb CH. The measurement of blood pressure and its interpretation. Prim Care 1980; 7: 637-651.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7010403&dopt=Abs tract
Evidenzklasse: IV


56. Reeves RA. Does this patient have hypertension? How to measure blood pressure. JAMA 1995; 273: 1211-1218.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7707630&dopt=Abs tract
Evidenzklasse: IV


57. O´Brien ET et al. ABC of blood pressure measurement. Technique. BMJ 1979; ii: 982-984.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=509184&dopt=Abstr act
Evidenzklasse: IV


58. Campbell NR et al. Errors in assessment of blood pressure: blood pressure measuring technique. C J Public Health 1994; 85: S18-21.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7804946&dopt=Abs tract
Evidenzklasse: IV


59. O´Brien ET et al. ABC of blood pressure measurement. The patient. BMJ 1979; ii: 920-921.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=519230&dopt=Abstr act
Evidenzklasse: IV


60. Neufeld PD et al. Observer error in blood pressure measurement. CMAJ 1986; 135: 633-637.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3756693&dopt=Abs tract
Evidenzklasse: Ib


61. O`Brien ET et al. ABC of blood pressure measurement. The observer. BMJ 1979; ii: 775-776.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=519193&dopt=Abstr act
Evidenzklasse: IV


62. Mader SL. Effects of meals and time of day on postural blood pressureresponses in young and elderly subjects. Arch Intern Med 1989; 149: 2757-2760.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2596944&dopt=Abs tract
Evidenzklasse: IV


63. Le Pailleur C et al. The effects of talking, reading, and silence on the "white coat" phenomenon in hypertensive patients. Am J Hypertens 1998; 11: 203-207.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9524049&dopt=Abs tract
Evidenzklasse: Ib


64. Scriven AJ et al. Changes in blood pressure and plasma catecholamines caused by tyramine and cold exposure. J Cardiovasc Pharmacol 1984; 6: 954- 960.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6209506&dopt=Abs tract
Evidenzklasse: IIa


65. Kenney MJ et al. Postexercise hypotension. Key features, mechanisms, and clinical significance. Hypertension 1993; 22: 653-664.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8225525&dopt=Abs tract
Evidenzklasse: IV


66. Pescatello LS et al. Short-term effects of dynamic exercise on arterial blood pressure. Circulation 1991; 83: 1557-1561.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2022015&dopt=Abs tract
Evidenzklasse: IV


67. Cleroux J et al. Aftereffects of exercise on regional and systemic hemodynamics in hypertension. Hypertension 1992; 19:183-191.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1737653&dopt=Abs tract
Evidenzklasse: IV


68. Szasz JJ et al. Effect on distension of the bladder and contraction of sphincters on blood pressure. BMJ 1967; ii: 208-210.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6023104&dopt=Abs tract
Evidenzklasse: IV


69. Yagi S et al. Blood pressure in the paretic arms of patients with stroke. N Engl J Med 1986; 315: 836.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3748101&dopt=Abs tract
Evidenzklasse: IV


70. Messerli FH et al. Osler´s maneuver and pseudohypertension. N Engl J Med 1985; 312: 1548-1551.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=4000185&dopt=Abs tract
Evidenzklasse: IV


71. Oliner CM et al. Low predicitive value of positive Osler manoeuvre for diagnosing pseudohypertension. J Hum Hypertens 1993; 7: 65-70.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8450523&dopt=Abs tract
Evidenzklasse: IV


72. Freestone S et al. Effect of coffee and cigarette smoking on the blood pressure of untreated and diuretic-treated hypertensive patients. Am J Med 1982; 73: 348-353.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7124761&dopt=Abs tract
Evidenzklasse: IV


73. Potter JF et al. The pressor and metabolic effects of alcohol in normotensive subjects. Hypertension 1986;8: 625-631.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3522422&dopt=Abs tract
Evidenzklasse: Ib


74. Netea RT et al. Does it matter whether blood pressure measurements are taken with subjects sitting oder supine? J Hypertens 1998; 16: 263-268.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9557918&dopt=Abs tract
Evidenzklasse: Ib


75. Jamieson MJ et al. The measurement of blood pressure: sitting or supine, once or twice? J Hypertens 1990; 8: 635-640.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2168453&dopt=Abs tract
Evidenzklasse: Ib


76. Ohkubo Tet al. Relation between nocturnal decline in blood pressure and mortality. The Ohsama Study Am J Hypertens 1997;10: 1201-7.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9397237&dopt=Abs tract
Evidenzklasse: IIb


77. Mochizuki Y et al. Limited reproducibility of circadian variation in blood pressure dippers and nondippers. Am J Hypertens 1998; 11: 403-9.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9607377&dopt=Abs tract
Evidenzklasse: III


78. Ramsay LE et al. Guidelines for the management of hypertension: Report of the Third Working Party of the British Hypertension Society. J Hum Hypertens 1999, 13: 569-592.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10482967&dopt=Ab stract
 


79. Hansson L et al, for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9635947&dopt=Abs tract
Evidenzklasse: Ib


80. Staessen JA et al. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305-1315.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1168421&dopt=Abs tract
Evidenzklasse: Ia


81. Gueyffier F, Fromment A, Gouttin M. New meta-analysis of treatment trails of hypertension: improving the estimate of therapeutic benefit. J Hum Hypertens 1996; 10: 1-8.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8642184&dopt=Abs tract
Evidenzklasse: Ia


82. Quan A, Kerlikowske K, GueyffierQuan A, Kerlikowske K, Gueyffier F et al. Efficacy of treating hypertension in women. J Gen Intern Med 1999; 14: 718-29.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10632816&dopt=Ab stract
Evidenzklasse: Ia


83. Beto BA, Bansal VK, Quality of life in treatment of hypertension. A metaanalysis of clinical trials. Am J Hypertens 1992;: 5: 125-33.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1349484&dopt=Abs tract
Evidenzklasse: Ia


84. Croog SH, Levine S, Testa MA et al. The effects of antihypertensive drug therapy on the quality of life. N Engl J Med 1986; 314: 1657-64.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3520318&dopt=Abs tract
Evidenzklasse: Ib


85. Psaty BM, Smith NL, Siscovick DS et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277: 739-45.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9042847&dopt=Abs tract
Evidenzklasse: Ia


86. Hoppe UC, Beuckelmann DJ, Erdmann E. Bei welchen Antihypertensiva ist eine Reduktion von Letalität und Mortalität gesichert? Herz/Kreislauf 1997; 29: 202-06
Evidenzklasse: IV


87. Deutsche Liga zur Bekämpfung des hohen Blutdrucks e.V. Deutsche Hypertonie Gesellschaft. Empfehlungen zur Hochdruckbehandlung. 13. Aufl. Heidelberg 1997


88. Wright JM. Choosing an first-line drug in the management of elevated blood pressure. What is the evidence? 1. Thiazide diuretics. CMAJ 2000; 163: 57-60.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10920733&dopt=Ab stract
Evidenzklasse: Ia


89. Materson BJ et al, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 1993; 328: 914-921.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8446138&dopt=Abs tract
Evidenzklasse: Ib


90. Wright, J.M., Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 3: Angiotensin-converting-enzyme inhibitors. Cmaj, 2000. 163(3): p. 293-6.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10951729&dopt=Ab stract
Evidenzklasse: Ia


91. Wright JM et al. Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? CMAJ 1999; 161: 2522-32.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10420860&dopt=Ab stract
Evidenzklasse: Ia


92. Messerli FH et al. Are beta-blockers efficacoious as first line therapy for hypertension in the elderly? A systematic review. JAMA 1998; 279: 1903-7.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9634263&dopt=Abs tract
Evidenzklasse: Ia


93. Wright JM. Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 2. Beta-blockers. CMAJ 2000; 163: 188-92.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10934984&dopt=Ab stract
Evidenzklasse: Ia


94. Merlo J et al. Incidence of myocardial infarction in elderly being treated with antihypertensive drugs: population based cohort study BMJ 1996; 313: 457-461.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8776312&dopt=Abs tract
Evidenzklasse: III


95. Yusuf S. et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiocvascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators [published erratum appears in N Engl J Med 2000; 342: 748], N Engl J Med 2000; 342: 145-53.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10639539&dopt=Ab stract
Evidenzklasse: Ib


96. Staessen JA et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-64.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9297994&dopt=Abs tract
Evidenzklasse: Ib


97. Hansson L. et al. Randomised trial of effects of calcium antagonists on cardiovascular morbidity and mortality in hypertension. The Nordic Diltiazem (DORDIL) Study. Lancet 2000; 356: 359-65.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10972367&dopt=Ab stract
Evidenzklasse: Ib


98. ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomised to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) JAMA 2000; 283:1967-75.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10789664&dopt=Ab stract
Evidenzklasse: Ib


99. Neaton JD et al, for the Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension. Final Results JAMA 1993; 270: 713-724.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8336373&dopt=Abs tract
Evidenzklasse: Ib


100. Philip T et al on behalf of the HANE-trial research group. Randomised, double-blind, multicentre comparison of hydrochlothiazide, atenolol, nitrendipine and enalapril in antihypertensive treatments: results from the HANE study. BMJ 1997; 315: 154-159.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9251545&dopt=Abs tract
Evidenzklasse: Ib


101. Ramsay LE et al. Interpretation of prospective trials in hypertension: do treatment guidelines accurately reflect current evidence? J Hypertens 1996;14 (Supl 5): S 187-S194.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9120677&dopt=Abs tract
Evidenzklasse: IV


102. Thijs L et al. A meta-analysis of outcome trials in elderly hypertensives. J Hypertens1992;10: 1103-1109.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1334990&dopt=Abs tract
Evidenzklasse: Ia


103. Liu L et al. Comparison of active treatment and placebo in older chinese patients with isolated systoliic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group J Hypertens 1998; 16: 1823-29.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9869017&dopt=Abs tract
Evidenzklasse: Ib


104. Hansson L et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP). Lancet 1999; 353: 611-615.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10030325&dopt=Ab stract
Evidenzklasse: Ib


105. Gueyffier F et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomised controlled trials. Arch Intern Med 1997; 126: 761-767.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9148648&dopt=Abs tract
Evidenzklasse: Ia


106. SHEP Collaborative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolatred systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2046107&dopt=Abs tract
Evidenzklasse: Ib


107. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Working Group report on primary prevention of hypertension. Arch Intern Med 1993; 153: 186-208.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8422207&dopt=Abs tract
Evidenzklasse: IV


108. Watt GCM. Prevention of high blood pressure and ist complications: strategic issues in a local context. J Hypertens 1995; 13: 377-383.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7629397&dopt=Abs tract
Evidenzklasse: IV


109. Whelton PK. Epidemiology of hypertension. Lancet 1994; 344: 101-106.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7912348&dopt=Abs tract
Evidenzklasse: IV


110. Stamler J. Setting the TONE for ending the hypertension epidemic. JAMA 1998; 279: 878-879.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9516005&dopt=Abs tract
Evidenzklasse: IV


111. Appel LJ et al. For the DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336: 1117-1124.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9099655&dopt=Abs tract
Evidenzklasse: Ib


112. Applegate WB et al. Nonpharmacologic intervention to reduce blod pressure inolder patients with mild hypertension. Arch Intern Med. 1992; 152: 1162-1166.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1599343&dopt=Abs tract
Evidenzklasse: Ib


113. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials of Hypertension Prevention, Phase II Arch Intern Med 1997; 157: 657-667.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9080920&dopt=Abs tract
Evidenzklasse: Ib


114. Whelton PK et al, for the TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons. A randomised controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 1998; 279: 839-846
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9515998&dopt=Abs tract
Evidenzklasse: Ib


115. Fotherby MD, Potter JF. Potassium supplementation reduces clinic and ambulatory blood pressure in elderly hypertensive patients. J Hypertens 1992; 10: 1403-1408.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1336526&dopt=Abs tract
Evidenzklasse: Ib


116. Geleijnse JM et al. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. BMJ 1994; 309: 436-440.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7920126&dopt=Abs tract
Evidenzklasse: Ib


117. Fotherby MD, Potter JF. Effects of moderate sodium restriction on clinic and twenty-four-hour ambulatory blood pressure in elderly hypertensive subjects. J Hypertens 1993; 11: 657-663.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8397245&dopt=Abs tract
Evidenzklasse: Ib


118. Braith RW et al. Moderate- and high-intensity exercise lowers blood pressure in normotensive subjects 60-79 years of age. Am J Cardiol 1994; 73: 1124-1128.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8198040&dopt=Abs tract
Evidenzklasse: Ib


119. Kokkinos PF et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med 1995; 333: 1462-1467.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7477146&dopt=Abs tract
Evidenzklasse: Ib


120. McCarron DA et al. Nutritional management of cardiovascular risk factors. A randomised controlled trial. Arch Intern Med 1997; 157: 169-177.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9009974&dopt=Abs tract
Evidenzklasse: Ib


121. Appel LJ et al. For the DASH Collaborative Research Group. A Clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336: 1117-1124.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9099655&dopt=Abs tract
Evidenzklasse: Ib


122. Singer DRJ et al. Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. Hypertension 1995; 25: 1042-1044.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7737713&dopt=Abs tract
Evidenzklasse: Ib


123. Whelton PK et al, for the TONE Colaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons. A randomised controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 1998; 279: 839-846.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9515998&dopt=Abs tract
Evidenzklasse: Ib


124. Law MR, Frost CD, Wald NJ. III-analysis of data from trials of salt reduction. BMJ 1991; 302: 819-824.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1827353&dopt=Abs tract
Evidenzklasse: Ia


125. Midgley JP, Matthew AG, Greenwood CMT, Logan AG. Effect of reduced dietary sodium on blood pressure. A meta-analysis of randomised controlled trials. JAMA 1996; 275: 1590-1597.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8622251&dopt=Abs tract
Evidenzklasse: Ia


126. Kaplan NM. Alcohol and Hypertension. Lancet 1995; 345: 1588-1589.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7783532&dopt=Abs tract
Evidenzklasse: IV


127. Gill JS et al. Stroke and alkohol consumption. N Engl J Med 1986; 315: 1041-1046.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2876380&dopt=Abs tract
Evidenzklasse: III


128. Cushman WC et al, for the PATHS Group. Prevention and Treatment of Hypertension Study (PATHS): Effects of an alcohol treatment program on blood pressure. Arch Intern Med 1998; 158: 657-667.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9625399&dopt=Abs tract
Evidenzklasse: Ib


129. McElduff P, Dobson A. How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a mojor coronary event. BMJ 1997; 314: 1159-1164.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9146388&dopt=Abs tract
Evidenzklasse: III


130. Applegate WB et al. Nonpharmacologic intervention to reduce blood pressure in older patients with mild hypertension. Arch Intern Med 1992; 152: 1162-1166.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1599343&dopt=Abs tract
Evidenzklasse: Ib


131. Kokkinos PF et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med 1995; 333: 1462-1467.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7477146&dopt=Abs tract
Evidenzklasse: Ib


132. Jones, D. W., L. J. Appel, et al. (2003). “Measuring blood pressure accurately: new and persistent challenges.” Jama 289(8): 1027-30.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12597757&dopt=Ab stract
Evidenzklasse: IV


133. Arroll B, Beaglehole R. Exercise for hypertension. Lancet 1993; 341: 1248-1249.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8098398&dopt=Abs tract
 


134. Kaplan, N.M., Angiotensin II receptor antagonists in the treatment of hypertension. Am Fam Physician, 1999. 60(4): p. 1185-90.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10507747&dopt=Ab stract
Evidenzklasse: IV


135. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342(19):1378-84.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10805822&dopt=Ab stract  
Evidenzklasse: III


136. Whelton PK et al. Effects of oral potassium on blood pressure : Meta-analysis of randomised controlled trials. JAMA 1997; 277: 1624-1632.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9168293&dopt=Abs tract
Evidenzklasse: Ia


137. Williams C. Healthy eating: clarifying advice about fruit and vegetables. BMJ 1995; 310: 1453-1455.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7613282&dopt=Abs tract
Evidenzklasse: IV


138. Brown, M.J., et al., Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet, 2000. 356(9227): p. 366-72.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10972368&dopt=Ab stract
Evidenzklasse: Ib


139. Andersson OK et al. Survival in treated hypertension: follow up study after two decades. BMJ 1998; 317: 167-171. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9665894&dopt=Abs tract
Volltext:
http://www.bmj.com/cgi/content/full/317/7152/167
Evidenzklasse: III


140. Raw M, McNeill A, West R. Smoking cessation: evidence based recommendations for the healthcare system. BMJ 1999; 318: 182-185. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9888919&dopt=Abs tract
Volltext:
http://www.bmj.com/cgi/content/full/318/7177/182
Evidenzklasse: IV


141. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998; 80 (Suppl 2): S1-S29.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10193438&dopt=Ab stract


142. Tang JL et al. Systematic review of dietary intervention trials to lower blood total cholesterol in free living subjects. BMJ 1998; 316: 1213-1220.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9552999&dopt=Abs tract
Evidenzklasse: Ia


143. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. Imperial Cancer Research Fund OXCHECK Study Group. BMJ 1995; 310: 1099-1104.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7742676&dopt=Abs tract
Evidenzklasse: Ib


144. Whelton PK. Epidemiology of hypertension. Lancet 1994;344(8915):101-6.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7912348&dopt=Abs tract
Evidenzklasse: IV


145. Hasnain S, Webster J, McLay JS. Cardiovascular risk in hypertension: implications of the Sheffiled table for lipid-lowering strategy. J Hum Hypertens 1998; 12: 469-471.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9702933&dopt=Abs tract
Evidenzklasse: III


146. Peto R et al. Antihypertensive drug therapy: effects on stroke and coronary heart disease. In: Swales JD (ed.) Textbook of Hypertension. Blackwell; Oxford, 1994; pp 1156-64.
Evidenzklasse: IV


147. Gueyffier R et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomised controlled trials. Ann Intern Med 1997; 126: 761-767.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9148648&dopt=Abs tract
Evidenzklasse: Ia


148. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2046107&dopt=Abs tract
Evidenzklasse: Ib


149. Siscovick DS et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994; 330: 1852-1857.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8196728&dopt=Abs tract
Evidenzklasse: III


150. Collins R et al. Blood pressure, stroke, and coronary heart disease. Part 2. short-term reductions in blood pressure; overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-838.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1969567&dopt=Abs tract
Evidenzklasse: Ia


151. Isles CG et al. Mortality in patients of the Glasgow blood pressure clinic. J Hypertens 1986;4: 141-1576.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3711657&dopt=Abs tract
Evidenzklasse: IIa


152. Clausen J et al. Blood pressure and mortality: an epidemiological survey with 10 years follow-up. J Hum Hypertens 1992;6: 53-59.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1583631&dopt=Abs tract
Evidenzklasse: III


153. Thürmer HL et al. Blood pressure treatment as effective in a population sting as in controlled trials? Results from a prospective study. J Hypertens 1994; 12: 481-490.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8064174&dopt=Abs tract
Evidenzklasse: III


154. Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L. Survival in treated hypertension: follow up study after two decades. Bmj 1998;317(7152):167-71.
Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9665894&dopt=Abs tract
Volltext:
http://www.bmj.com/cgi/content/full/317/7152/167
Evidenzklasse: III


155. Du X et al. Case-control study of stroke and the quality of hypertension control in the north west England. BMJ 1997; 314: 272-276.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9022492&dopt=Abs tract
Evidenzklasse: III


156. United Kingdom prospective diabetes study group. Tight blood pressure control and risk of macrovascular and microvascular morbidity and mortality in type 2 diabetes. UKPDS 38. BMJ 1998; 317: 707-713. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9732337&dopt=Abs tract
Volltext:
http://www.bmj.com/cgi/content/full/317/7160/703
Evidenzklasse: Ib


157. Stanton AV. Calcium channel Blockers. The jury is still out on whether they cause heart attacks and suicide. BMJ 1998; 316: 1471-1473.
Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9582126&dopt=Abs tract
Volltext:
http://www.bmj.com/cgi/content/full/316/7143/1471
Evidenzklasse: IV


158. Cutler JA. Calcium channel blockers for hypertension – uncertainty continues. N Engl J Med 1998; 338: 679-681.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9486999&dopt=Abs tract
Evidenzklasse: IV


159. Packer M et al. For the Prospective Randomized Amlodipin Survival Evaluation Study Group. Effect of amlodipin on morbidity and mortality in severe chronic heart failure. N Engl. J Med. 1996; 335: 1197-1114.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8813041&dopt=Abs tract
Evidenzklasse: Ib


160. Gong L et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996;14: 1237-1245.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8906524&dopt=Abs tract
Evidenzklasse: Ib


161. Beevers DG et al. Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension . Is there a risk? BMJ 1996; 312: 1143-1145.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8620133&dopt=Abs tract
Evidenzklasse: IV


162. Tuomilehto J et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl  Med 1999; 340: 677-684.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10053176&dopt=Ab stract
Evidenzklasse: Ib


163. Materson BJ et al, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Results of combination antihypertensive therapy after failure of each of the components. J Hum Hypertens 1995; 9: 791-796.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8576893&dopt=Abs tract
Evidenzklasse: Ib


164. The Medical Research Council´s General Practice Research Framework. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet 1998; 351: 233-241.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9457092&dopt=Abs tract
Evidenzklasse: Ib


165. Shepherd J et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterinaemia. N Engl J Med 1995; 333: 1301-1307.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7566020&dopt=Abs tract
Evidenzklasse: Ib


166. Downs JR et al. Primary prevention of acute coronary events with lovastatinin men and women with average cholesterol levels. Results of AFCAPS/TexCAPS. JAMA 1998; 279: 1615-1622.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9613910&dopt=Abs tract
Evidenzklasse: Ib


167. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7968073&dopt=Abs tract
Evidenzklasse: Ib


168. Sacks FM et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-1009.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8801446&dopt=Abs tract
Evidenzklasse: Ib


169. UI Haq I et al: Lipid-Lowering for prevention of coronary heart disease: what policy now? Clin Sc 1996; 91: 399-413.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8983865&dopt=Abs tract
Evidenzklasse: IV


170. Standing Medical Advisory Committee. The use of statins. Department of Health, London 1997.
Evidenzklasse: IV


171. Colhoun HM et al. Blood pressure screening, management and control in England, results from the health survey for England 1994; J Hypertens 1998; 16: 747-753.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9663914&dopt=Abs tract
Evidenzklasse: III


172. Lever A et al. Treatment of hypertension in the elderly. J Hypertens 1995; 13: 571-579.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7594412&dopt=Abs tract
Evidenzklasse: Ia


173. Kostis JB et al, for the SHEP Collaborative Research Group. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1997;278: 212-216.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9218667&dopt=Abs tract
Evidenzklasse: Ib


174. Forette F et al. Prevention of dementia in randomised placebo controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 1347-1357.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9802273&dopt=Abs tract
Evidenzklasse: Ib


175. Levy D et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557-1562.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8622246&dopt=Abs tract
Evidenzklasse: III


176. Dickerson JEC et al. Management of hypertension in general practice: agreements with and variations from the British Hypertension Society guidelines. J Hum Hypertens 1995;9: 835-839.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8576900&dopt=Abs tract
Evidenzklasse: IV


177. Dickerson JEC et al. Influence of age on general practitioners´ definition and treatment of hypertension. BMJ 1995; 310:574.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7888934&dopt=Abs tract
Evidenzklasse: III


178. Midgley JP et al. Effect of reduced dietary sodium on blood pressure. A meta-analysis of randomised controlled trials. JAMA 1996; 275: 1590-1697.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8622251&dopt=Abs tract
Evidenzklasse: Ia


179. Adler A et al. Risk of macrovascular and microvascular complications of diabetes at different levels of blood pressure-observations from the UKPDS (Abstract). Diabetes 1999; 48:A16.
Evidenzklasse: Ib


180. Johnston CI et al. Meeting report of the International Society of Hypertension conference on hypertension and diabetes. J Hypertens 1992; 10: 393-397.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1316406&dopt=Abs tract
Evidenzklasse: IV


181. Colhoun HM et al. The scope for cardiovascular disease risk factor intervention among people with diabetes in England. Diabetic Med 1999;16:35-40.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10229291&dopt=Ab stract
Evidenzklasse: III


182. Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998; 352:213-219.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9683226&dopt=Abs tract
Evidenzklasse: IV


183. Lewis EJ et al, for the Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8413456&dopt=Abs tract
Evidenzklasse: Ib


184. Mogensen CE et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995;346:1080-1084.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7564792&dopt=Abs tract
Evidenzklasse: IV


185. Parving HH. Initiation and progression of diabetic nephropathy. N Engl J Med 1996; 335: 1682-1683.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8929369&dopt=Abs tract
Evidenzklasse: IV


186. Lazarus JM et al, for the Modification of Diet in Renal Disease Study Group. Achievement and safety of a low blood pressure goal in chronic renal disease. Hypertension 1997;29: 641-650.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9040451&dopt=Abs tract
Evidenzklasse: Ib


187. The Euclid Study Group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349: 1787-1792.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9269212&dopt=Abs tract
Evidenzklasse: Ib


188. Williams B. Lisinopril and albumin excretion in diabetes. Lancet 1997; 350: 663-664.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9288063&dopt=Abs tract
Evidenzklasse: IV


189. The Hypertension in Diabetes Study Group. Hypertension in Diabetes Study (HDS): 1. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications, J Hypertens 1993; 11: 309-317.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8387089&dopt=Abs tract
Evidenzklasse: Ib


190. Turner RC et al. UKPDS 23: risk factors for coronary artery disease in non-insulin dependent diabetes. BMJ 1998; 316: 823-838.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9549452&dopt=Abs tract
Evidenzklasse: Ib


191. UKPDS-Group 39: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 1998; 317: 713-720. Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9732338&dopt=Abs tract
Volltext:
http://www.bmj.com/cgi/content/full/317/7160/713
Evidenzklasse: Ib


192. Wesseling, H. [Lowering of diastolic blood pressure < or = 90 mmHg should not be attempted, except in type 2 diabetics; the 'Hypertension optimal treatment' (HOT) trial]. Ned Tijdschr Geneeskd 1999; 143(23): 1188-91.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10389531&dopt=Ab stract
Evidenzklasse: Ib


193. Birkenhager, W. H., J. A. Staessen, et al. Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial. J Nephrol 2000; 13(3): 232-7.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10928302&dopt=Ab stract
Evidenzklasse: Ib


194. Birkenhager, W. H. and J. A. Staessen. Treatment of diabetic patients with hypertension. Curr Hypertens Rep 1999; 1(3): 225-31.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10981070&dopt=Ab stract
Evidenzklasse: Ia


195. Tuomilehto J et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Syst Eur Investigators. N Engl J Med 1999 ; 340: 677-684.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10053176&dopt=Ab stract
Evidenzklasse: Ib


196. Curb JD et al. Effect of diuretic-based antihypertensive treatment on cardiovascular risk in people with diabetes. Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. JAMA 1996; 276: 1886-1892.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8968014&dopt=Abs tract
Evidenzklasse: Ib


197. Gall MA et al. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study, BMJ 1997;314: 783-788.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9080995&dopt=Abs tract
Evidenzklasse: III


198. Ravid M et al. Long-term renoprotective effect of angiotensin converting enzyme inhibitors in non-insulin dependent diabetes: a seven year follw up: Arch Intern Med 1996;156: 286-289.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8572838&dopt=Abs tract
Evidenzklasse: Ib


199. Williams B. Insulin resistance: the shape of things to come. Lancet 1994; 344: 521-524.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7914619&dopt=Abs tract
Evidenzklasse: IV


200. Heise, T., E. Jennen, et al. (2001). Optimierte Hypertonietherapie. Z Arztl Fortbild Qualitatssich 95(5): 349-55.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11486499&dopt=Ab stract
Evidenzklasse: IV


201. Smith WCS, Lee AJ, Crombie IK, Tunstall-Pedoe H. Control of blood pressure in Scotland: the rule of halves. BMJ 1990; 300: 871-983.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2344507&dopt=Abs tract
Evidenzklasse: III


202. Mashru M. Lant A. Interpractice audit of diagnosis and management of hypertension in primary care: educational intervention and review of medical records. BMJ 1997; 314: 942-946.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9099120&dopt=Abs tract
Evidenzklasse: III


203. Wilhelmsen L, Strasser T, on behalf of the Study Collaborators. WHO-WHL hypertension management audit project: J Hum Hypertens 1993; 7: 257-263.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8345493&dopt=Abs tract
Evidenzklasse: III


204. Carney S, Gillies A, Smith A, Taylor M. Hypertension education: patient knowledge and satisfaction. J Hum Hypertens 1993; 7; 505-508.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8263893&dopt=Abs tract
Evidenzklasse: III


205. Taylor FC, Ebrahim S. Prevention of cardiovascular disease in hypertensive patients in general practice: improving quality of care. Br J Cardiol 1997; 4: 331-335
Evidenzklasse: IV


206. Zarnke, K.B., et al., The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure. Can J Cardiol, 2001. 17(12): p. 1249-63.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11773936&dopt=Ab stract


207. McAlister, F.A., et al., The 2000 Canadian recommendations for the management of hypertension: Part one--therapy. Can J Cardiol, 2001. 17(5): p. 543-59.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11381277&dopt=Ab stract


208. Prisant, L.M., et al., American National Standard for nonautomated sphygmomanometers. Summary report. Am J Hypertens, 1995. 8(2): p. 210-3.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7755953&dopt=Abs tract


209. Thürmann, P.A., Pharmakotherapie der Hypertonie. Z Arztl Fortbild Qualitatssich, 2001. 95(5): p. 345-8.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11486498&dopt=Ab stract
Evidenzklasse: IV


210. Donner-Banzhoff, N., Perspektiven der Hypertoniebehandlung in der hausärztlichen Praxis. Z Arztl Fortbild Qualitatssich, 2001. 95(5): p. 333-8.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11486496&dopt=Ab stract
Evidenzklasse: IV


211. Health Care Guideline: “Preventive Services for Adults“ des Institute for Clinical Systems Improvement (ISCI), 2001.
http://www.icsi.org/guide/PrvSvA.pdf


212. Stamler, J., Blood pressure and high blood pressure. Aspects of risk. Hypertension, 1991. 18(3 Suppl): p. I95-107.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1889862&dopt=Abs tract
Evidenzklasse: IV


213. WHO-ISH, et al., 1999 World Health Organization - International Society of Hypertension: Guidelines for the Management of Hypertension. J Hypertens, 1999. 17: p. 151-85.
http://www.who.int/ncd/cvd/ht_guide.html


214. Mancia, G., et al., Blood-pressure control in the hypertensive population. Lancet, 1997. 349(9050): p. 454-7.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9040574&dopt=Abs tract
Evidenzklasse: III


215. Kleinert, H. D., G. A. Harshfield, et al. (1984). “What is the value of home blood pressure measurement in patients with mild hypertension?” Hypertension 6(4): 574-8.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6235190&dopt=Abs tract
Evidenzklasse: III


216. Ohkubo, T., et al., Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population- based observation in Ohasama, Japan. J Hypertens, 1998. 16(7): p. 971-5.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9794737&dopt=Abs tract
Evidenzklasse: III


217. Ambulante 24-Stunden Blutdruckmessung. Dtsch Med Wochenschr, 1998. 123(47): p. 1426-30.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9874595&dopt=Abs tract
Evidenzklasse: IV


218. Middeke, M. and J. Schrader, Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension. Bmj, 1994. 308(6929): p. 630-2.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8148712&dopt=Abs tract
Evidenzklasse: III


219. Verdecchia, P., et al., Sex, cardiac hypertrophy and diurnal blood pressure variations in essential hypertension. J Hypertens, 1992. 10(7): p. 683-92.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1321197&dopt=Abs tract
Evidenzklasse: III


220. Mancia, G., et al., Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation, 1997. 95(6): p. 1464-70.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9118514&dopt=Abs tract
Evidenzklasse: III


221. Perloff, D., et al., Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens Suppl, 1989. 7(3): p. S3-10.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2527294&dopt=Abs tract
Evidenzklasse: III


222. Staessen, J.A., et al., Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. Jama, 1999. 282(6): p. 539-46.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10450715&dopt=Ab stract
Evidenzklasse: Ib


223. Verdecchia, P., et al., Prognostic significance of the white coat effect. Hypertension, 1997. 29(6): p. 1218-24.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9180621&dopt=Abs tract
Evidenzklasse: III


224. Kario, K., et al., Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension, 1996. 27(1): p. 130-5.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8591875&dopt=Abs tract
Evidenzklasse: IIb


225. Bianchi, S., et al., Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens, 1994. 7(1): p. 23-9.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8136107&dopt=Abs tract
Evidenzklasse: III


226. Franz, I.W., Blood pressure measurement during ergometric stress testing. Z Kardiol, 1996. 85(Suppl 3): p. 71-5.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8896303&dopt=Abs tract
Evidenzklasse: IV


227. Lollgen, H., H.V. Ulmer, and P. Crean, Recommendations and standard guidelines for exercise testing. Report of the Task Force Conference on Ergometry, Titisee 1987. Eur Heart J, 1988. 9 Suppl K: p. 3-37.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3073955&dopt=Abs tract


228. Mundal, R., et al., Exercise blood pressure predicts cardiovascular mortality in middle- aged men. Hypertension, 1994. 24(1): p. 56-62.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8021008&dopt=Abs tract
Evidenzklasse: III


229. Wilson, N.V. and B.M. Meyer, Early prediction of hypertension using exercise blood pressure. Prev Med, 1981. 10(1): p. 62-8.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7232344&dopt=Abs tract
Evidenzklasse: III


230. Dlin, R.A., et al., Follow-up of normotensive men with exaggerated blood pressure response to exercise. Am Heart J, 1983. 106(2): p. 316-20.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6869213&dopt=Abs tract
Evidenzklasse: III


231. Leibel, B., I. Kobrin, and D. Ben-Ishay, Exercise testing in assessment of hypertension. Br Med J (Clin Res Ed), 1982. 285(6354): p. 1535-6.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6814635&dopt=Abs tract
Evidenzklasse: IV


232. Nathwani, D., et al., Left ventricular hypertrophy in mild hypertension: correlation with exercise blood pressure. Am Heart J, 1985. 109(2): p. 386-7.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3155587&dopt=Abs tract
Evidenzklasse: IIb


233. Ren, J.F., et al., Exercise systolic blood pressure: a powerful determinant of increased left ventricular mass in patients with hypertension. J Am Coll Cardiol, 1985. 5(5): p. 1224-31.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3157737&dopt=Abs tract
Evidenzklasse: IIb


234. Filipovsky, J., P. Ducimetiere, and M.E. Safar, Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension, 1992. 20(3): p. 333-9.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1387630&dopt=Abs tract
Evidenzklasse: III


235. Medizinisches Wissensnetzwerk evidence.de: Leitlinie „Diagnose, Therapie und Versorgung bei Demenz“. Version 12/2001.
http://www.evidence.de/Leitlinien/leitlinien-intern/Demenz_Start/demenz_start.html


236. Klein, R., et al., Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol, 1994. 112(1): p. 92-8.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8285901&dopt=Abs tract
Evidenzklasse: III


237. Fagard, R.H., J.A. Staessen, and L. Thijs, Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension, 1997. 29(1 Pt 1): p. 22-9.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9039075&dopt=Abs tract
Evidenzklasse: IIb


238. Zanchetti, A., et al., Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens, 1998. 16(7): p. 949-61.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9794735&dopt=Abs tract
Evidenzklasse: Ib


239. Krijnen, P., et al., A clinical prediction rule for renal artery stenosis. Ann Intern Med, 1998. 129(9): p. 705-11.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9841602&dopt=Abs tract
Evidenzklasse: III


240. Jalil, N.D., et al., Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE). Eur J Surg, 1998. 164(1): p. 23-8.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9537705&dopt=Abs tract
Evidenzklasse: III


241. Geiger, H., et al., Decrease of blood pressure by ventrolateral medullary decompression in essential hypertension. Lancet, 1998. 352(9126): p. 446-9.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9708753&dopt=Abs tract
Evidenzklasse: IIb


242. Dluhy, R.G. and R.P. Lifton, Glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab, 1999. 84(12): p. 4341-4.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10599685&dopt=Ab stract
Evidenzklasse: IV


243. Palmer, B.F. and R.J. Alpern, Liddle's syndrome. Am J Med, 1998. 104(3): p. 301-9.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9552093&dopt=Abs tract
Evidenzklasse: IV


244. Palermo, M., et al., Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf), 1996. 45(5): p. 605-11.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8977758&dopt=Abs tract
Evidenzklasse: IIb


245. Schuster, H., et al., Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nat Genet, 1996. 13(1): p. 98-100.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8673114&dopt=Abs tract
Evidenzklasse: IV


246. Naraghi, R., et al., Neurovascular compression at the ventrolateral medulla in autosomal dominant hypertension and brachydactyly. Stroke, 1997. 28(9): p. 1749-54.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9303020&dopt=Abs tract
Evidenzklasse: IIb


247. Oberman, A., et al., Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status. Ann Intern Med, 1990. 112(2): p. 89-95.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1967210&dopt=Abs tract
Evidenzklasse: Ib


248. Reisin, E., et al., Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med, 1978. 298(1): p. 1-6.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=337144&dopt=Abstr act
Evidenzklasse: III


249. Appel, L.J., et al., A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med, 1997. 336(16): p. 1117-24.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9099655&dopt=Abs tract
Evidenzklasse: Ib


250. Knust, U., et al., [A pilot study on the long-term effects of combined drug therapy and psychophysiologically-oriented therapy in patients with severe essential hypertension]. Wien Klin Wochenschr, 1991. 103(6): p. 163-8.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2035277&dopt=Abs tract
Evidenzklasse: III


251. Margolin, G., et al., Blood pressure lowering in elderly subjects: a double-blind crossover study of omega-3 and omega-6 fatty acids. Am J Clin Nutr, 1991. 53(2): p. 562-72.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1989427&dopt=Abs tract
Evidenzklasse: Ib


252. Toft, I., et al., Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Ann Intern Med, 1995. 123(12): p. 911-8.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7486485&dopt=Abs tract
Evidenzklasse: Ib


253. Nenseter, M.S., et al., Effect of Norwegian fish powder on risk factors for coronary heart disease among hypercholesterolemic individuals. Nutr Metab Cardiovasc Dis, 2000. 10(6): p. 323-30.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11302007&dopt=Ab stract
Evidenzklasse: Ib


254. Rissanen, T., et al., Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation, 2000. 102(22): p. 2677-9.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11094031&dopt=Ab stract
Evidenzklasse: III


255. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994; 343: 139-42.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7904003&dopt=Abs tract
Evidenzklasse: Ia


256. Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA 1994; 271: 1940-7.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8201739&dopt=Abs tract
Evidenzklasse: Ia


257. Stevens, V.J., et al., Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. Arch Intern Med, 1993. 153(7): p. 849-58.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8466377&dopt=Abs tract
Evidenzklasse: Ib


258. Hebert, P.R., et al., Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med, 1993. 153(5): p. 578-81.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8439221&dopt=Abs tract
Evidenzklasse: Ia


259. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997; 349: 747-52.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9074572&dopt=Abs tract
Evidenzklasse: Ib


260. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. Jama, 1970. 213(7): p. 1143-52.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=4914579&dopt=Abs tract
Evidenzklasse: III


261. Estacio, R.O., et al., The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med, 1998. 338(10): p. 645-52.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9486993&dopt=Abs tract
Evidenzklasse: Ib


262. Tatti, P., et al., Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care, 1998. 21(4): p. 597-603.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9571349&dopt=Abs tract
Evidenzklasse: Ib


263. Lindberg, G., et al., Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study. Bmj, 1998. 316(7133): p. 741-5.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9529409&dopt=Abs tract
Evidenzklasse: III


264. Dahlöf, B., et al., Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet, 1991. 338(8778): p. 1281-5.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1682683&dopt=Abs tract
Evidenzklasse: Ib


265. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed), 1985. 291(6488): p. 97-104.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2861880&dopt=Abs tract
Evidenzklasse: Ib


266. Amery, A., et al., Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet, 1985. 1(8442): p. 1349-54.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2861311&dopt=Abs tract
Evidenzklasse: Ib


267. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. Bmj, 1992. 304(6824): p. 405-12.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1445513&dopt=Abs tract
Evidenzklasse: Ib


268. MacMahon, S., Blood pressure and the risk of cardiovascular disease. N Engl J Med, 2000. 342(1): p. 50-2.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10620650&dopt=Ab stract
Evidenzklasse: IV


269. van den Hoogen, P.C., et al., The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med, 2000. 342(1): p. 1-8.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10620642&dopt=Ab stract
Evidenzklasse: IV


270. MacMahon, S., B. Neal, and A. Rodgers, Blood pressure lowering for the primary and secondary prevention of coronary and cerebrovascular disease. Schweiz Med Wochenschr, 1995. 125(51-52): p. 2479-86.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8571098&dopt=Abs tract
Evidenzklasse: IV


271. Kannel, W.B., Clinical misconceptions dispelled by epidemiological research. Circulation, 1995. 92(11): p. 3350-60.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7586324&dopt=Abs tract
Evidenzklasse: IV


272. Kannel, W.B., A.L. Dannenberg, and R.D. Abbott, Unrecognized myocardial infarction and hypertension: the Framingham Study. Am Heart J, 1985. 109(3 Pt 1): p. 581-5.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3976481&dopt=Abs tract
Evidenzklasse: III


273. Wilhelmsen, L., et al., Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens, 1987. 5(5): p. 561-72.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2892881&dopt=Abs tract
Evidenzklasse: Ib


274. Wikstrand, J., et al., Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. Jama, 1988. 259(13): p. 1976-82.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3346979&dopt=Abs tract
Evidenzklasse: Ib


275. Wikstrand, J., et al., Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study. Hypertension, 1991. 17(4): p. 579-88.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2013485&dopt=Abs tract
Evidenzklasse: Ib


276. Mulrow, C.D., Primary Prevention, in Clinical Evidence, S.W. Barton, Editor. 2001, BMJ Publishing Group: London.
Evidenzklasse: Ia


277. Luft, F.C., STOPPING at the CAPPP of good HOPE. Nephrol Dial Transplant, 2000.15(4): 451-2.
Medline:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10727535&dopt=Ab stract
Volltext:
http://ndt.oupjournals.org/cgi/content/full/15/4/451
Evidenzklasse: IV


278. Hansson, L., et al., Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet, 1999. 354(9192): p. 1751-6.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10577635&dopt=Ab stract
Evidenzklasse: Ib


279. Hansson, L., First-line antihypertensive therapy. Lancet, 2000. 356(9228): p. 508-9.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10981915&dopt=Ab stract
Evidenzklasse: IV


280. Vasan, R.S., et al., Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men: The Framingham Heart Study. Jama, 2002. 287(8): p. 1003-10.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11866648&dopt=Ab stract
Evidenzklasse: III


281. Elmer, P.J., et al., Lifestyle intervention: results of the Treatment of Mild Hypertension Study (TOMHS). Prev Med, 1995. 24(4): p. 378-88.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7479629&dopt=Abs tract
Evidenzklasse: Ib


282. Grossman, E.B. and E.R. Black, Secondary Hypertension, in Diagnostic Strategies for common medical problems, E.R. Black, et al., Editors. 1999, American College of Physicians: Philadelphia.
Evidenzklasse: IV


283. Kuhlmann, U., D. Walb, and F.C. Luft, Hypertonie, in Nephrologie. Pathophysiologie - Klinik - Praxis, U. Kuhlmann, D. Walb, and F.C. Luft, Editors. 1998, Georg Thieme Verlag: Stuttgart. p. 369-401.
Evidenzklasse: IV


284. Pahor, M., et al., Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet, 2000. 356(9246): p. 1949-54.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11130522&dopt=Ab stract
Evidenzklasse: Ia


285. Luft, F.C., Recent clinical trial highlights in hypertension. Curr Hypertens Rep, 2001. 3(2): p. 133-8.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11276395&dopt=Ab stract
Evidenzklasse: IV


286. Neal, B., S. MacMahon, and N. Chapman, Effects of ACE inhibitors, calcium antagonists, and other blood- pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet, 2000. 356(9246): p. 1955-64.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11130523&dopt=Ab stract
Evidenzklasse: Ia


287. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet, 2001. 358(9287): p. 1033-41.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11589932&dopt=Ab stract
Evidenzklasse: Ib


288. Kolloch, R. and E. Offers, [Treatment concepts in therapy refractory hypertension]. Fortschr Med, 1998. 116(18-19): p. 22-6.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9691533&dopt=Abs tract
Evidenzklasse: IV


289. Grossman, E., F.H. Messerli, and U. Goldbourt, Does diuretic therapy increase the risk of renal cell carcinoma? Am J Cardiol, 1999. 83(7): p. 1090-3.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10190526&dopt=Ab stract
Evidenzklasse: IIa


290. Dahlof, B., et al., Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet, 2002. 359(9311): p. 995-1003.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11937178&dopt=Ab stract
Evidenzklasse: Ib


291. Lindholm, L.H., et al., Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet, 2002. 359(9311): p. 1004-10.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11937179&dopt=Ab stract
Evidenzklasse: Ib


292. Kjeldsen, S.E., et al., Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation. Blood Press, 2001. 10(2): p. 83-91.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11467764&dopt=Ab stract
Evidenzklasse: Ib


293. Brunner, H.R. and H. Gavras, Angiotensin blockade for hypertension: a promise fulfilled. Lancet, 2002. 359(9311): p. 990-2.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11937175&dopt=Ab stract
Evidenzklasse: IV


294. MRC/BHF Heart Protection Study Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360(9326):7-22.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12114036&dopt=Ab stract
Evidenzklasse: Ib


295. ÄZQ, BÄK, AkdÄ, FDS, AWMF, DDG, DGIM: Nationale Versorgungs-Leitlinie Typ 2 Diabetes (Kurzfassung). 1 Auflage: Mai 2002, korrigiert 1.7.2002, 1-23.
http://www.leitlinien.de/azq/ll/content/versorgungsleitlinien/index/diabetes/pdf/nvldiabetes


296. McGee SR. Evidence-Based Physical Diagnosis. Philadelphia: W.B. Saunders Company; 2001.
Evidenzklasse: Ia


297. Baumgarten P. Gruppentherapie in der Arztpraxis. Eine Darstellung anhand von Fallbeispielen betreuter und evaluierter Hochdruckgruppen. Diplomarbeit im Bereich Gesundheitswissenschaften, Universität Bielefeld;1991.
Evidenzklasse: IV


298. Rödder HD. Neue Empfehlungen der Hochdruckliga vorgestellt. Angiotensin-II-Antagonisten stehen jetzt gleichberechtigt auf der Stufe der Erstbehandlung. Ärzte Zeitung 2002 15.11.2002.
http://www.aerztezeitung.de/docs/2002/11/15/207a0501.asp
Evidenzklasse: IV


299. Rietbrock N, Staib AH, Loew D. Klinische Pharmakologie - Arzneitherapie. Darmstadt: Steinkopff Verlag; 2001.
Evidenzklasse: IV


300. Suwelack B, Gerhardt U, Hohage H. Therapie der hypertensiven Krise. Med Klin 2000;95(5):286-92.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10850068&dopt=Ab stract
Evidenzklasse: IV


301. Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, et al. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich) 2002;4(6):393-405.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12461301&dopt=Ab stract
Evidenzklasse: Ib


302. Svensson P, de Faire U, Sleight P, Yusuf S, Ostergren J. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy. Hypertension 2001;38(6):E28-32.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11751742&dopt=Ab stract
Volltext:
http://www.hypertensionaha.org/cgi/content/full/38/6/e28
Evidenzklasse: Ib


303. Ferrari P, Ostini E, Allemann Y, de Courten M, Weidmann P. [Diagnostic value of ambulatory daily blood pressure profile: comparison with measurements performed by a laboratory technician]. Schweiz Med Wochenschr 1992;122(36):1317-24.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1411388&dopt=Abs tract
Evidenzklasse: III


304. van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000;342(14):1007-14.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10749962&dopt=Ab stract
Evidenzklasse: Ib


305. Rudnick KV, Sackett DL, Hirst S, Holmes C. Hypertension in a family practice. Can Med Assoc J 1977;117(5):492-7.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=902191&dopt=Abstr act
Evidenzklasse: III


306. Mair N, Magometschnigg G, Hitzenberger K, Neumann K. Die klinische Prüfung der Messgenauigkeit von Blutdruckselbstmessgeräten. Journal Hypertension 2000(4):6-26.
Volltext:
http://149.148.224.4/kup/pdf/388.pdf
Evidenzklasse: III


307. Estacio RO, Schrier RW. Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial. Am J Cardiol 1998;82(9B):9R-14R.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9822137&dopt=Abs tract
Evidenzklasse: Ib


308. Duncan BB, Wong TY, Tyroler HA, Davis CE, Fuchs FD. Hypertensive retinopathy and incident coronary heart disease in high risk men. Br J Ophthalmol 2002;86(9):1002-6.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12185127&dopt=Ab stract
Evidenzklasse: III


309. Appel LJ. The verdict from ALLHAT--thiazide diuretics are the preferred initial therapy for hypertension. Jama 2002;288(23):3039-42.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12479770&dopt=Ab stract
Evidenzklasse: IV


310. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Jama 2002;288(23):2981-97.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12479763&dopt=Ab stract
Evidenzklasse: Ib


311. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). Jama 2002;288(23):2998-3007.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12479764&dopt=Ab stract
Evidenzklasse: Ib


312. Pepine CJ, Handberg-Thurmond E, Marks RG, Conlon M, Cooper-DeHoff R, Volkers P, et al. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension. J Am Coll Cardiol 1998;32(5):1228-37.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9809930&dopt=Abs tract
Evidenzklasse: Ib


313. Keltai M, Johnson JA, Kowey PR, Ried LD, Tueth M. INVEST substudies: design and patient characteristics. Clin Cardiol 2001;24(11 Suppl):V9-11.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11712776&dopt=Ab stract
Evidenzklasse: Ib


314. Reincke M, Seiler L, Rump LC. Normokaliämischer primärer Hyperaldosteronismus. Deutsches Ärzteblatt 2003;100(4):A184-190.
Volltext:
http://www.deutsches-aerzteblatt.de/v4/archiv/pdf.asp?id=35287
Evidenzklasse: IV


315. Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, et al. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003;348(7):583-92.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12584366&dopt=Ab stract
Evidenzklasse: Ib


316. Nelson MR, Reid CM, Krum H, Muir T, Ryan P, McNeil JJ. Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national blood pressure study cohort. Bmj 2002;325(7368):815.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12376444&dopt=Ab stract
Evidenzklasse: III


317. Vollmar HC, Koneczny N, Floer B, Isfort J, Kunstmann W, Butzlaff M. Evidenzbasierte Leitlinien als Instrumente des Wissenstransfers in die Praxis. Die Arbeitsweise des medizinischen Wissensnetzwerks evidence.de. Fortschr Med 2002;120(Originalien IV/2002):125-130.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12613269&dopt=Ab stract
Evidenzklasse: IV


318. Davis, D.A. and A. Taylor-Vaisey, Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. Cmaj, 1997. 157(4): 408-16.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9275952&dopt=Abs tract
Evidenzklasse: Ia


319. Freeman, A.C. and K. Sweeney, Why general practitioners do not implement evidence: qualitative study. Bmj, 2001. 323(7321): 1100-1105.
http://bmj.com/cgi/content/abstract/323/7321/1100
Evidenzklasse: III


320. Grol, R., Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care, 2001. 39(8 Suppl 2): II46-54.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11583121&dopt=Ab stract
Evidenzklasse: IV


321. Ollenschlaeger, G., H. Kirchner, and M. Fiene, Leitlinien in der praktischen Medizin - scheitern sie an der Umsetzung. Internist, Der, 2001. 42: 473-83.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11326730&dopt=Ab stract
Evidenzklasse: IV


322. Medizinisches Wissensnetzwerk evidence.de der Universität Witten/Herdecke: Leitlinie “Kopfschmerzen und Migräne” Version 4/2003
http://www.evidence.de/Leitlinien/leitlinien-intern/Kopfschmerzen_Start/kopfschmerzen_start.html


323. Donner-Banzhoff N, ARRIBA-HERZ - Absolutes und relatives Risiko- Individuelle Beratung in der Allgemeinpraxis. Eigenverlag: Zu bestellen über norbert@mailer.uni-marburg.de


324. Stetter, F., S. Kupper: Autogenetic training: a meta-analysis of clinical outcome studies: Appl Psychophysiol Biofeedback 2002; 27: 45-98
Evidenzklasse: Ia


[325] Vollmar HC, Koneczny N, Floer B, Butzlaff M.
Evidenzbasiertes Wissen im Internet für Ärzte und Patienten
in Jaeckel A: Telemedizinführer Deutschland 2003. Deutsches Medizin Forum: Darmstadt; 2002
Evidenzklasse: IV


[326] Butzlaff M, Koneczny N, Floer B, Vollmar HC, Lange S, Kunstmann W, Köck C.
Hausärzte, Internet und neues Wissen. Nutzung und Effizienzeinschätzung von fortbildungsmedien durch Allgemeinärzte und hausärztlich tätige Internisten.
Med Klin. 2002 Jul 15;97(7):383-388.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12168475&dopt=Ab stract
Evidenzklasse: Ib


[327] Butzlaff M, Floer B, Koneczny N, Vollmar HC, Lange S, Isfort J, Kunstmann W.
www.evidence.de - Netzbasierte Leitlinien im Praxistest. Beurteilung und Nutzung von evidenzbasierten und netzgestützten Leitlinien durch Allgemeinärzte und hausärztlich tätige Internisten.
Z Arztl Fortbild Qualitatssich. 2002 Feb;96(2):127-33
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11921609&dopt=Ab stract
Evidenzklasse: Ib

 


 

 

[Start Leitlinien] [» Asthma] [» Kopfschmerzen] [» Hypertonie] [Algorithmus] [Diagnostik Text] [Therapie Text] [Hintergründe] [Referenzen] [Patientenleitlinie] [Impressum] [» Otitis media] [» Gallensteine] [» Herzinsuffizienz] [» Demenz] [» Harnwegsinfekt] [» KR-Karzinom] [» Dekubitus] [Ihre Meinung?] [Interne Infos]

Eine Aktualisierung dieser Leitlinien ist nicht geplant (Stand September 2007)

 

 

® Medizinisches Wissensnetzwerk evidence.de der Universität Witten/Herdecke Patienten...

Update:03/09/09

webmaster: www.ju-ko.de